Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Shenni Holdings's EBITDA for the
six
months ended in Sep. 2024 was $2.60 Mil. Shenni Holdings's Revenue for the
six
months ended in Sep. 2024 was $11.18 Mil. Therefore, Shenni Holdings's EBITDA margin for the quarter that ended in Sep. 2024 was 23.28%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Shenni Holdings EBITDA Margin % Related Terms
Shenni Holdings EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Shenni Holdings's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenni Holdings EBITDA Margin % Chart
Shenni Holdings Annual Data
Trend
Mar23
Mar24
EBITDA Margin %
-3.74
19.45
Shenni Holdings Semi-Annual Data
Mar23
Sep23
Mar24
Sep24
EBITDA Margin %
0.00
26.24
18.55
23.28
SNI vs : EBITDA Margin % Comparison
For the Medical Devices subindustry, Shenni Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenni Holdings EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenni Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Shenni Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenni Holdings (SNI) has a EBITDA Margin % of 23.28% as of Sep. 2024. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shenni Holdings and its competitors.
Is Shenni Holdings' EBITDA Margin % too high?
Shenni Holdings' current EBITDA Margin % is 23.28%. The Medical Devices & Instruments industry median EBITDA Margin % is 7.52. Shenni Holdings' value of 23.28% is 209.6% above this industry median.
How does Shenni Holdings' EBITDA Margin % compare to ?
Shenni Holdings' EBITDA Margin % of 23.28% can be compared against companies in the Medical Devices & Instruments industry. The industry median EBITDA Margin % is 7.52. Shenni Holdings' value of 23.28% is 209.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.52, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenni Holdings's current EBITDA Margin % of 23.28% is 209.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shenni Holdings and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenni Holdings's current EBITDA Margin % is 23.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenni Holdings stock overvalued right now?
Shenni Holdings (SNI) has a current EBITDA Margin % of 23.28%. The current EBITDA Margin % is 23.28% and 209.6% above the Medical Devices & Instruments industry median of 7.52. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Shenni Holdings (SNI), the current EBITDA Margin % is 23.28% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AddressBiopharmaceutical Industry Park, South Bridge Yongfeng County, Jiangxi Province, Jian, CHN, 331500
Shenni Holdings Ltd is a holding company. Through its operating subsidiaries in China, it is engaged in the business of the manufacture and distribution of urology medical devices and care products as well as the distribution of cardiovascular and cerebrovascular medical devices. Its products include Guide Wire, Catheter Sheath, and PTA Balloon Catheter. The company derives its revenue from three sources: (i) sales and distribution of urology medical devices (ii) sales and distribution of urology care products, and (iii) sales and distribution of cardiovascular and cerebrovascular medical devices.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNI has been successfully added to your 
